Global Intravenous Anesthetics Market Technological Advancements 2026-2033

The global intravenous anesthetics market is on a steady growth path, with demand projected to rise from about USD 4.6 billion in 2026 to roughly USD 7.9 billion by 2033, reflecting a CAGR of 8.1% over the forecast period. Growth is being shaped by the expansion of surgical volumes, rising use of day-care procedures, and the preference for fast-acting agents that allow tighter control of sedation and quicker recovery. The market includes induction and maintenance agents, sedatives used in procedural settings, and supporting formulations that are administered directly into the bloodstream for predictable onset and depth of anesthesia. Demand is also being reinforced by higher procedure complexity, aging populations, and the need for reliable anesthesia management in both hospitals and ambulatory centers.

From 2019 to 2025, the market moved through a period of uneven but clear expansion, starting near USD 3.2 billion in 2019 and reaching around USD 4.3 billion by 2025 as elective surgeries recovered after the pandemic disruption and healthcare systems rebuilt operating room activity. The 2026 base year is estimated at USD 4.6 billion, supported by broader procedure normalization, stronger adoption of short-acting agents, and more intensive use in ambulatory surgery. By 2033, the market should reach close to USD 7.9 billion, with unit demand rising faster than value in some countries because of generic penetration, while specialty and premium formulations continue to support pricing in advanced systems. The growth curve is not linear, but the underlying trajectory remains positive because anesthesia is tied directly to surgical throughput, hospital investment, and procedural innovation.

The United States remains the largest single market, with 2026 demand close to USD 1.5 billion and expected growth near 7.5% annually through 2033, supported by high surgical intensity, advanced hospital networks, and strong ambulatory surgery penetration. The country’s market is shaped by purchasing discipline, payer pressure, and the preference for agents that reduce recovery time and improve operating room turnover. China is expanding even faster, with 2026 demand around USD 620 million and a forecast CAGR above 10%, driven by hospital build-out, rising middle-class access to surgery, and a steady shift toward standardized anesthesia protocols. Investment in domestic pharmaceutical manufacturing is also changing supply patterns, making China a more important production base as well as a major consumption market.

Germany continues to anchor European demand with 2026 market size near USD 260 million, supported by a large surgical base, high procedural standards, and strong use of intravenous agents in tertiary hospitals. Growth is steady rather than explosive, but public procurement discipline and an aging population keep volumes firm, while hospital consolidation supports more centralized purchasing. Japan holds a similar strategic position, with 2026 demand around USD 240 million and a moderate growth outlook, reflecting an older population, highly organized surgical care, and widespread use of controlled anesthesia in complex procedures. In both countries, the market is less about broad expansion and more about replacement demand, consistency of supply, and preference for clinically dependable formulations.

India is becoming one of the most important growth stories, with 2026 demand estimated at USD 180 million and annual growth near 11%, helped by private hospital expansion, medical tourism, and rising access to elective procedures across tier 2 and tier 3 cities. Volume growth is strong, but pricing remains sensitive, which makes generics central to the competitive mix and keeps procurement highly cost driven. South Korea, by contrast, is a smaller but premium market at about USD 110 million in 2026, where advanced hospital capabilities and high procedure density support demand for modern anesthesia products. Italy and France together form a meaningful Western European base, with Italy near USD 150 million and France around USD 190 million in 2026, both supported by aging demographics, surgical throughput, and hospital-led purchasing that favors stable, proven supply.

The United Kingdom is valued at roughly USD 170 million in 2026, with demand affected by backlog management, NHS purchasing practices, and ongoing pressure to improve theatre utilization. Canada contributes about USD 95 million, with moderate growth tied to public hospital budgets and an increasing focus on efficient ambulatory procedures, while Mexico is near USD 90 million and Brazil around USD 210 million, both benefiting from broader access to surgery but constrained by uneven reimbursement and imported product dependence. Turkey, at close to USD 75 million, sits between Europe and the Middle East in both procurement style and growth profile, while Indonesia and Vietnam, estimated at USD 80 million and USD 70 million respectively, are seeing faster increases as hospital capacity improves and private healthcare expands. Stats N Data’s market structure analysis suggests that these emerging markets will contribute a disproportionate share of incremental volume through 2033, even if their average selling prices remain below Western levels.

Saudi Arabia and the United Arab Emirates together represent a high-value Gulf corridor, with 2026 demand of about USD 65 million and USD 45 million respectively, supported by well-funded hospital systems, medical tourism ambitions, and heavy use of imported premium products. South Africa is smaller at roughly USD 40 million, but it remains the leading African market because of its referral hospitals and private healthcare segment, though budget pressure and supply consistency remain issues. Australia is estimated at USD 85 million, with stable growth led by well-organized surgical care and strong adoption of agents that support day surgery. Thailand, Spain, the Netherlands, Poland, Malaysia, and Argentina collectively add a broad middle layer of demand, with 2026 values of about USD 60 million, USD 145 million, USD 75 million, USD 55 million, USD 65 million, and USD 50 million respectively, each shaped by local reimbursement, import reliance, and the balance between public and private care.

By type, the market is led by induction agents, maintenance agents, and procedural sedation products, with induction drugs holding the largest share because they are used across nearly every surgical setting. Propofol remains central to overall consumption, while other intravenous agents serve niche or specialized roles depending on patient profile, procedure length, and clinician preference. By application, hospitals account for the largest share, followed by ambulatory surgical centers and specialty clinics, since most high-acuity procedures still rely on hospital operating rooms and recovery infrastructure. By region, North America leads in value, Europe follows with strong institutional purchasing, and Asia Pacific is the fastest-growing area because of expanding surgical access, larger patient pools, and more aggressive healthcare investment. Across the market, Stats N Data observed that the most attractive segments are those combining high procedure frequency with short recovery expectations, which favors products that can support faster turnover and lower postoperative burden.

Several drivers are sustaining demand, beginning with the global rise in surgical procedures linked to cancer care, cardiovascular treatment, orthopedics, and cosmetic surgery. Aging populations are especially important because older patients often require more complex anesthesia management and more frequent monitoring, which increases the use of controlled intravenous agents. Another major driver is the shift toward ambulatory and minimally invasive surgery, where speed of onset and recovery time are commercially valuable to hospitals and payers alike. The market also benefits from higher expectations around patient safety and standardization, which encourages providers to choose agents with predictable pharmacokinetics and easy titration.

At the same time, the market faces real restraints that limit pricing and complicate procurement. Generic competition is intense, especially in propofol and other widely used agents, and this keeps margins thin for suppliers that do not have scale or contract strength. Regulatory scrutiny around safety, controlled substance handling, and manufacturing quality can slow launches and raise compliance costs. Supply continuity is another pressure point, since intravenous anesthetics often depend on a limited group of manufacturers and concentrated production networks, making shortages a recurring risk in some markets. Cost containment efforts by hospital systems, particularly in Europe and public-sector markets, also restrict premium pricing even when clinical demand is rising.

Opportunities are strongest in emerging markets, where surgical access is still expanding and many facilities are modernizing operating theaters and recovery units. Growth is also available in bundled service models that combine drug supply, training, and perioperative support, especially in hospitals seeking better throughput and lower wastage. Product differentiation can still matter in formulations that improve stability, reduce infusion complexity, or support safer administration in high-risk patients. In this context, the most successful suppliers will be those that combine manufacturing efficiency with local regulatory strength and hospital-facing commercial execution. The market’s next phase will likely reward companies that can offer both dependable supply and measurable operating room value.

Challenges remain concentrated around procurement pressure, clinician preference shifts, and the need to maintain sterile, high-quality production at scale. Hospitals often switch suppliers based on availability or contract pricing, which makes customer retention difficult unless manufacturers provide reliable service and consistent supply. In several regions, public tender systems create sharp price competition that can compress profitability even as unit demand rises. Operational risk is also elevated by the need to manage cold-chain or controlled storage requirements in some settings, along with the possibility of substitution if anesthesiologists are forced to adapt to shortages. These factors make market share less about brand loyalty alone and more about execution, reliability, and regulatory trust.

Technology trends are reshaping how intravenous anesthetics are used and sold. Target-controlled infusion systems, better monitoring tools, and digital anesthesia records are helping clinicians deliver more precise dosing and reduce variability in patient response. Formulation work is also improving product stability and compatibility, which matters for hospitals that want smoother workflow and fewer preparation errors. There is growing interest in agent combinations and protocols that support rapid emergence, lower postoperative nausea, and shorter discharge times. As procurement teams become more data driven, manufacturers that can demonstrate workflow and recovery advantages will have a clearer commercial edge.

Regional patterns remain distinct, with North America leading on value, Europe on institutional consistency, Asia Pacific on volume growth, and the Middle East on premium procurement. Latin America is more uneven, but countries with larger private healthcare sectors are gradually lifting procedural demand and import volumes. In Europe, cross-border supply discipline and centralized tenders shape competitiveness, while in Asia Pacific the main story is capacity expansion and greater access to surgery. Middle Eastern buyers often prioritize quality, branded confidence, and supplier reliability, which supports higher average prices than in many emerging markets. These regional differences mean that a single go-to-market strategy is rarely effective across the whole industry.

The competitive landscape is shaped by a mix of global pharmaceutical groups, specialty anesthesia suppliers, and regional generic manufacturers. Competition is defined less by number of products and more by supply reliability, regulatory standing, hospital relationships, and pricing discipline. Large companies tend to win in systems where procurement favors scale and consistency, while regional players can compete effectively in cost-sensitive markets if they maintain quality and distribution reach. Several buyers now evaluate suppliers on service continuity and contract flexibility as much as on product specifications, which creates room for differentiated commercial models. In practice, the strongest players are those that can protect supply while keeping costs low enough to stay on formularies and tender lists.

The analytical approach used here combines historical demand reconstruction, procedure-linked consumption modeling, country-level healthcare spending patterns, and forward assumptions about surgical activity, reimbursement, and manufacturing capacity. 2026 is treated as the reference year, with 2019 to 2025 used to calibrate the market through the pandemic period and recovery phase, and 2026 to 2033 used for forecasting based on expected utilization trends and pricing behavior. Where country estimates were needed, the analysis weighted hospital procedure volumes, private sector participation, import dependence, and local drug adoption patterns. This method is useful because intravenous anesthetics are not a standalone discretionary category; they move with surgery, infrastructure, and operating room efficiency, which makes demand forecasting more dependable when tied to healthcare utilization.

Strategically, suppliers should prioritize supply security, cost-efficient manufacturing, and stronger hospital partnerships rather than relying only on product breadth. In mature markets, winning depends on contract resilience, shortage prevention, and proof that products help reduce recovery time or improve operating room flow. In faster-growing countries, commercial success will come from local registration capability, distributor discipline, and products that fit public procurement thresholds without sacrificing quality. Manufacturers that can balance premium clinical positioning in advanced economies with affordable access in emerging ones will be best placed to capture share through 2033.

The intravenous anesthetics market serves as a crucial component of modern medical procedures, offering rapid and effective sedation for patients undergoing various surgical and diagnostic interventions. These anesthetics are utilized across a diverse range of healthcare settings, including hospitals, outpatient surgery centers, and emergency care, providing a solution that minimizes pain and discomfort while ensuring patient safety. As the demand for minimally invasive procedures grows, driven by factors such as an increasing aging population and a rise in chronic diseases, the intravenous anesthetics market has witnessed significant evolution. A recent report by STATS N DATA indicates that the market is currently valued at several billion dollars, reflecting both its historical growth and the increasing acceptance of advanced anesthetic techniques.

Growth projections for the intravenous anesthetics market are robust, with analysts predicting a compound annual growth rate (CAGR) of over 6% in the coming years. Key market drivers contributing to this expansion include advancements in anesthetic technology, the rising prevalence of surgical procedures, and an increasing focus on patient comfort. Innovations in drug formulation, such as the development of anesthetics with faster onset and shorter duration, are playing a pivotal role in enhancing procedural efficiency and patient satisfaction. However, the market is not without its challenges; potential restraints such as regulatory hurdles, the risk of adverse events, and the high cost of newer anesthetic agents could hinder growth.

Opportunities within the intravenous anesthetics market are plentiful, particularly regarding the development of novel anesthetics and improved delivery systems. Increased collaboration between pharmaceutical companies and healthcare providers aims to address unmet needs and enhance the efficacy of anesthesia care. Technological advancements, like the integration of digital health solutions and monitoring systems, are further transforming the landscape of intravenous anesthetics, allowing for tailored sedation strategies and improved patient outcomes. As the healthcare sector continues to evolve, the intravenous anesthetics market is poised for significant growth, driven by innovation, patient-centered care, and a deeper understanding of pain management techniques.

Understanding the latest trends in the INTRAVENOUS ANESTHETICS MARKET is crucial for businesses aiming to stay ahead in today's fast-paced environment. Our detailed market research report provides companies and investors with valuable insights into the Global Intravenous Anesthetics Industry. This report goes beyond basic data analysis, offering advanced forecasts, revenue estimates, and future trends from 2026 to 2033. It is an essential tool for decision-makers navigating the complexities of this evolving market.

Market Overview and Trends

This report offers a comprehensive look at the current state of the Intravenous Anesthetics Market. By analyzing historical data, we uncover key industry insights and track the market's growth over time. This in-depth review provides a clear understanding of the Intravenous Anesthetics Market's current status, setting a solid foundation for assessing its future direction. By examining past trends, the report helps predict future growth, allowing stakeholders to adapt and take advantage of new opportunities.

Looking forward, the report includes expert predictions and a thorough analysis of future trends in the Intravenous Anesthetics Ecosystem. These growth projections outline the market's expected path, helping stakeholders navigate new opportunities. The report highlights significant growth drivers, such as technological advancements and rising demand in various sectors, while also noting potential challenges like regulatory hurdles and economic uncertainties.

Additionally, the report identifies several growth opportunities, offering strategic insights into both challenges and opportunities within the Intravenous Anesthetics Market. Understanding these dynamics equips stakeholders to make better decisions and develop strategies to succeed in a rapidly changing environment.

Market Segmentation

The Intravenous Anesthetics Market is divided into several categories, including product type, application/end-user, and geography. The segmentation includes:

Type

• Propofol
• Etomidate
• Ketamine
• Barbiturates

Application

• Hospitals
• Clinics
• Ambulatory Surgical Centers

Note: We can customize market segmentation upon request to better meet specific business needs and provide focused insights.

This section dives into the market's segmentation, showing how different components contribute to overall market dynamics. Each segment is assessed based on its size and growth rate, identifying areas of rapid expansion and those with stable growth. This analysis is key to spotting the segments that drive the market and hold strong potential for future development.

The report also includes a Intravenous Anesthetics Market attractiveness analysis, evaluating each segment's appeal based on factors like market potential, competitive intensity, and growth prospects. This gives a well-rounded view of which segments are most promising for investment and strategic initiatives, helping businesses allocate resources more effectively and maximize their returns.

Competitive Landscape

Key players featured in this report include:

• AstraZeneca
• Fresenius-Kabi
• AbbVie
• Baxter Healthcare
• B. Braun Melsungen

The Intravenous Anesthetics industry is highly competitive, with major players continuously striving to strengthen their positions and expand their reach. The report provides an in-depth look at the competitive landscape, profiling key players in the Intravenous Anesthetics Market and detailing their market shares. This section gives a clear picture of the main participants and their roles in the industry.

Additionally, the report includes a SWOT analysis for these major competitors, assessing their strengths, weaknesses, opportunities, and threats. This analysis offers a complete view of the competitive dynamics and strategic positioning of these companies. Knowing the strengths and weaknesses of competitors helps stakeholders identify areas for improvement and craft strategies to gain a competitive edge.

Recent Developments

The report covers recent key developments in the Global Intravenous Anesthetics Market, such as mergers, acquisitions, partnerships, and new product launches. These activities have significantly influenced the competitive landscape and shaped trends within the Intravenous Anesthetics industry. Staying updated on these developments helps stakeholders anticipate market shifts and adjust their strategies accordingly.

The report also includes a benchmarking analysis of key products and services. By comparing these offerings, the analysis highlights their performance and market positioning. This comparison is crucial for identifying industry best practices and areas that need improvement, providing valuable insights for stakeholders aiming to enhance their products and remain competitive.

Technological Advancements and Innovations

Technological advancements are a major force driving the Global Intravenous Anesthetics Market. Our report highlights the latest innovations and technological progress, showing how these developments are reshaping the Intravenous Anesthetics industry landscape.

Industry Dynamics and Structure

The report also examines the overall structure and dynamics of the Intravenous Anesthetics industry. This analysis provides a clear understanding of how the industry functions and evolves, highlighting the key components and their interactions. Understanding these elements helps stakeholders spot opportunities for collaboration and innovation, which are essential for driving market growth.

Competitive Analysis Using Porter's Five Forces

Our report uses Porter's Five Forces Analysis to assess the competitive landscape of the Intravenous Anesthetics Market. This framework looks at the bargaining power of buyers and suppliers, the threat of new entrants and substitute products, and the level of competition among existing players. This analysis helps identify the factors that influence the industry's profitability and competitiveness, providing stakeholders with essential insights for strategic decision-making.

Value Chain Analysis

The report includes a detailed value chain analysis, mapping the journey from suppliers to end-users. This analysis, backed by thorough market studies, provides insights into each phase of the process, highlighting where value is added and identifying potential areas for efficiency improvements. By optimizing the value chain, stakeholders can enhance their operational efficiency and gain a competitive advantage.

Customer Preferences and Trends

The report also highlights key customer preferences and trends, offering insights into what consumers expect from products and services in the Intravenous Anesthetics Market. Understanding these preferences helps businesses anticipate market trends and tailor their offerings accordingly, leading to improved customer satisfaction and business growth.

Regulatory Environment

This report thoroughly explores the regulations and standards affecting the Intravenous Anesthetics Market, offering a detailed look at the legal framework governing the industry. This information is crucial for understanding the rules and guidelines that market participants must follow. Staying updated on regulatory changes enables stakeholders to maintain compliance and avoid legal issues.

The report also assesses the impact of recent regulatory changes in the Intravenous Anesthetics industry and examines how these shifts shape the market. It provides stakeholders with insights to anticipate potential challenges and adapt their strategies accordingly. Understanding the regulatory landscape helps stakeholders make informed decisions and develop strategies that minimize risks while maximizing opportunities.

Furthermore, the report outlines the compliance requirements for participants in the Intravenous Anesthetics Market, detailing the steps needed to adhere to regulations and standards. Meeting these compliance demands is vital for maintaining legal and operational integrity within the market. Emphasizing compliance builds trust with customers and strengthens a company's market position.

Market Entry Strategy

Entering the Intravenous Anesthetics industry involves several challenges, including high barriers and strong competition. This report identifies the main obstacles that new entrants face when trying to enter the market, such as significant capital requirements, strict regulations, and intense competition from established players.

The report also details critical success factors for new entrants in the Intravenous Anesthetics market, focusing on key elements like innovation, effective marketing, strategic partnerships, and a strong value proposition. By addressing these aspects, new entrants can better navigate the market complexities and improve their chances of success.

Additionally, the report provides strategic recommendations for market entry, including practical advice on positioning, customer acquisition, and differentiation tactics. These strategies help new entrants establish a strong market presence and gain a competitive edge, enabling them to overcome entry barriers and capitalize on opportunities in the Intravenous Anesthetics Market.

Economic Indicators and Risk Analysis

The report explores how macroeconomic factors, such as GDP growth, inflation, and employment trends, impact the Intravenous Anesthetics Market. This analysis provides stakeholders with a comprehensive understanding of the broader economic environment and its influence on the market, supporting informed decision-making.

The report also examines the key risks and uncertainties in the Intravenous Anesthetics Market, highlighting potential challenges that could affect market stability and growth. These risks include economic volatility, regulatory changes, and strong market competition. By understanding these risks, stakeholders can develop strategies to mitigate them and enhance market resilience.

The report also offers specific strategies for mitigating identified risks. The impact assessment and mitigation section provides actionable recommendations to help Intravenous Anesthetics Market participants manage risks effectively and maintain stability. By addressing these risks proactively, stakeholders can protect their interests and support sustainable growth.

Investment Analysis

This research evaluates the key suppliers and distributors in the Intravenous Anesthetics Market, highlighting their capabilities, reliability, and strategic roles within the supply chain. Understanding these dynamics helps stakeholders optimize their operations and strengthen their market positions.

Additionally, the report identifies prime investment opportunities and provides strategic recommendations. It highlights areas with significant potential for high returns, helping investors make informed decisions about where to allocate resources for maximum impact. Strategic investments in these high-potential areas can boost profitability and drive market growth.

The report includes a comprehensive analysis of return on investment (ROI) and financial projections, which are essential for evaluating the expected profitability of investments and crafting informed financial strategies. Understanding these forecasts helps stakeholders assess potential returns and the risks associated with different investment options. By making data-driven investment decisions, stakeholders can maximize their returns and achieve their financial goals.

Furthermore, the report includes feasibility studies for potential new projects or ventures. These studies assess the viability of new initiatives by analyzing market demand, costs, and potential revenue. Such evaluations help investors make informed decisions about pursuing new opportunities. Engaging in feasible projects allows stakeholders to expand their market presence and foster business growth.

Technological and Innovation Insights

The Intravenous Anesthetics Market report explores emerging technologies and their potential impact on the market, highlighting how these advancements are setting the stage for the industry's future. This section focuses on innovations that could disrupt the market, creating new opportunities for growth and innovation.

The report also provides a detailed analysis of the innovation landscape and R&D activities within the Intravenous Anesthetics Market. It examines ongoing R&D efforts and the state of innovation, offering a clear view of how companies are driving progress and staying competitive. This analysis is crucial for understanding the role of innovation in market growth and identifying strategic investment areas.

Furthermore, the report explores the potential of disruptive technologies in the Intravenous Anesthetics Market. These technologies could reshape the industry, creating new opportunities and challenges. By staying informed about these emerging technologies, stakeholders can adjust their strategies and leverage innovation to maintain a competitive advantage.

Geographic Analysis

The report includes a detailed geographic analysis of the Intravenous Anesthetics Market, offering insights into regional trends and opportunities. This section covers key regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Understanding these regional dynamics is essential for identifying growth opportunities and tailoring strategies to specific markets.

Regional Insights

The analysis also highlights regional trends and developments, focusing on the main market drivers and challenges in each area. Understanding these regional dynamics helps stakeholders make informed decisions about market entry, expansion, and resource allocation.

Market Size and Growth Rate by Region

The report examines the market size and growth rate across different regions, providing a clear view of which areas are growing the fastest. This information is vital for identifying key markets and planning strategic initiatives.

Emerging Markets and Opportunities

The report identifies emerging markets with high growth potential, offering strategic recommendations for tapping into these opportunities. Understanding these emerging markets is crucial for stakeholders looking to expand their presence and access new growth areas.

Key Questions Addressed in This Report

This comprehensive report answers several key questions, ensuring that stakeholders gain a deep understanding of the Intravenous Anesthetics Market:

• What is the size of the Global Intravenous Anesthetics Market, and what growth rate is expected during the forecast period?

• What are the main factors driving the growth of the Intravenous Anesthetics Market?

• What challenges and risks does the Intravenous Anesthetics Market currently face?

• Who are the major players in the Intravenous Anesthetics Market?

• What trends are influencing the shares of the Intravenous Anesthetics Market?

• What insights can be drawn from applying Porter's Five Forces model to the Intravenous Anesthetics Market?

• What global expansion opportunities exist in the Intravenous Anesthetics Market?

Why Invest in this Intravenous Anesthetics Market Report

• Stay Informed:

  This exclusive research study keeps you updated with the latest information on the competitive landscape, helping you understand the strategies and positions of key players in the market.

• Access Analytical Data and Strategic Planning Methods:

  The report offers comprehensive analytical data and strategic planning tools that enable you to make informed decisions and develop strong market strategies.

• Deepen Understanding of Critical Product Segments:

  This report provides in-depth insights into key product segments, helping you understand their performance, trends, and market potential.

• Explore Market Dynamics Comprehensively:

  This report thoroughly examines the factors influencing market dynamics, providing an analysis of the drivers, challenges, opportunities, and constraints within the market.

• Access Regional Analyses and Business Profiles of Key Stakeholders:

  With detailed regional analyses and profiles of key stakeholders, this report provides insights into regional market conditions and the roles of major market participants.

• Gain Exclusive Insights into Factors Impacting Market Growth:

  Obtain exclusive insights into the factors driving market growth, helping you anticipate changes and adjust your strategies effectively.

Our market research report is an essential resource for investors and businesses seeking a deep understanding of the Global Intravenous Anesthetics Market. With comprehensive data, detailed analyses, and actionable insights, this report equips stakeholders with the knowledge they need to make informed decisions, develop successful strategies, and capitalize on the vast opportunities within the Intravenous Anesthetics industry. We recommend leveraging these insights to enhance strategic planning and secure a competitive edge in the Intravenous Anesthetics Market.